EA200000896A1 - S-ЗАМЕЩЕННЫЕ ТИОЛОВЫЕ ЭФИРЫ 11b-БЕНЗАЛЬДОКСИМЭСТРА-4,9-ДИЕНУГОЛЬНОЙ КИСЛОТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЭТИ СОЕДИНЕНИЯ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ - Google Patents

S-ЗАМЕЩЕННЫЕ ТИОЛОВЫЕ ЭФИРЫ 11b-БЕНЗАЛЬДОКСИМЭСТРА-4,9-ДИЕНУГОЛЬНОЙ КИСЛОТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЭТИ СОЕДИНЕНИЯ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ

Info

Publication number
EA200000896A1
EA200000896A1 EA200000896A EA200000896A EA200000896A1 EA 200000896 A1 EA200000896 A1 EA 200000896A1 EA 200000896 A EA200000896 A EA 200000896A EA 200000896 A EA200000896 A EA 200000896A EA 200000896 A1 EA200000896 A1 EA 200000896A1
Authority
EA
Eurasian Patent Office
Prior art keywords
benzaldoximestra
acid
substituted
dienugolic
compops
Prior art date
Application number
EA200000896A
Other languages
English (en)
Other versions
EA002766B1 (ru
Inventor
Герд Шуберт
Свен Ринг
Гюнтер Кауфманн
Вальтер Элгер
Биргит Шнайдер
Original Assignee
Йенафарм Гмбх Унд Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Йенафарм Гмбх Унд Ко. Кг filed Critical Йенафарм Гмбх Унд Ко. Кг
Publication of EA200000896A1 publication Critical patent/EA200000896A1/ru
Publication of EA002766B1 publication Critical patent/EA002766B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/006—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

В заявке описываются S-замещенные тиоловые эфиры 11β-бензальдоксимэстра-4,9-диенугольной кислоты общей формулы (I)и их фармацевтически приемлемые соли, а также способ получения этих соединений и содержащие их фармацевтические композиции. Предлагаемые соединения связываются на рецепторе прогестерона и обладают заметно сниженным антиглюкокортикоидным действием.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200000896A 1998-03-03 1999-02-10 S-ЗАМЕЩЕННЫЕ ТИОЛОВЫЕ ЭФИРЫ 11β-БЕНЗАЛЬДОКСИМЭСТРА-4,9-ДИЕНУГОЛЬНОЙ КИСЛОТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЭТИ СОЕДИНЕНИЯ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ EA002766B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19809845A DE19809845A1 (de) 1998-03-03 1998-03-03 S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
PCT/DE1999/000408 WO1999045023A1 (de) 1998-03-03 1999-02-10 S-SUBSTITUIERTE 11β-BENZALDOXIM-ESTRA-4,9-DIEN-KOHLENSÄURETHIOLESTER, VERFAHREN ZU DEREN HERSTELLUNG UND DIESE VERBINDUNGEN ENTHALTENE PHARMAZEUTISCHE ZUBEREITUNGEN

Publications (2)

Publication Number Publication Date
EA200000896A1 true EA200000896A1 (ru) 2001-04-23
EA002766B1 EA002766B1 (ru) 2002-08-29

Family

ID=7860080

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000896A EA002766B1 (ru) 1998-03-03 1999-02-10 S-ЗАМЕЩЕННЫЕ ТИОЛОВЫЕ ЭФИРЫ 11β-БЕНЗАЛЬДОКСИМЭСТРА-4,9-ДИЕНУГОЛЬНОЙ КИСЛОТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЭТИ СОЕДИНЕНИЯ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ

Country Status (28)

Country Link
US (1) US6365582B1 (ru)
EP (1) EP1060187B1 (ru)
JP (1) JP3796405B2 (ru)
KR (1) KR100488823B1 (ru)
CN (1) CN1208341C (ru)
AT (1) ATE237627T1 (ru)
AU (1) AU749163B2 (ru)
BG (1) BG64735B1 (ru)
BR (1) BR9908458A (ru)
CA (1) CA2322471C (ru)
CZ (1) CZ20003125A3 (ru)
DE (2) DE19809845A1 (ru)
DK (1) DK1060187T3 (ru)
EA (1) EA002766B1 (ru)
EE (1) EE04242B1 (ru)
ES (1) ES2197634T3 (ru)
HU (1) HUP0100962A3 (ru)
ID (1) ID26972A (ru)
IL (1) IL137851A (ru)
IS (1) IS5579A (ru)
NO (1) NO316977B1 (ru)
NZ (1) NZ506048A (ru)
PL (1) PL193687B1 (ru)
PT (1) PT1060187E (ru)
SK (1) SK284177B6 (ru)
TR (1) TR200002506T2 (ru)
UA (1) UA59437C2 (ru)
WO (1) WO1999045023A1 (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19906152B4 (de) 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
US8193252B1 (en) 1999-08-31 2012-06-05 Bayer Pharma AG Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders
AU781835B2 (en) * 1999-08-31 2005-06-16 Schering Aktiengesellschaft Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives
CO5200773A1 (es) * 1999-08-31 2002-09-27 Jenapharm Gmbh And Co Kg Mesoprogestinas (moduladores de receptores para progestero- na) como componente de composiciones utilizadas para la terapia de sustitucion hormonal (trh)
HUP0202429A3 (en) * 1999-08-31 2004-04-28 Schering Ag Use of mesoprogestins (progesterone receptor modulators) for the preparation of pharmaceutical compositions for the treatment and prevention of benign hormone dependent gynecological disorders
US7629334B1 (en) * 1999-08-31 2009-12-08 Bayer Schering Pharma Aktiengesellschaft Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT)
EP1285927A3 (de) * 2001-08-16 2005-06-29 Schering Aktiengesellschaft Verwendung von Glucocorticoid-Rezeptorantagonisten zur Vorbeugung und Behandlung von Erkrankungen des männlichen Reproduktionssystems
DE10221034A1 (de) 2002-05-03 2003-11-20 Schering Ag 17alpha-Fluoralkyl-11ß-benzaldoxim-Steroide, Verfahren zu deren Herstellung, diese Steroide enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
DE10236405A1 (de) * 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
AU2003255355A1 (en) * 2002-08-02 2004-02-25 Schering Aktiengesellschaft Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy
DE102005059222B4 (de) * 2005-12-08 2007-10-11 Bayer Schering Pharma Ag 11ß-Benzaldoximderivate von D-Homoestra-4,9-dien-3-onen
EP3693376A1 (en) 2006-10-24 2020-08-12 Allergan Pharmaceuticals International Limited Compositions for suppressing endometrial proliferation
CA2680119A1 (en) 2007-03-07 2008-09-12 Janssen Pharmaceutica N.V. Steroids derivatives as selective progesterone receptor modulators
TWI539953B (zh) 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
DE102009034525A1 (de) * 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
EP2550288A1 (en) 2010-03-22 2013-01-30 Repros Therapeutics Inc. Compositions and methods for non-toxic delivery of antiprogestins
EP2664325A1 (en) * 2012-05-16 2013-11-20 PregLem S.A. Methods for preventing or treating androgen mediated diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039677A (en) * 1976-03-01 1977-08-02 Syntex (U.S.A.) Inc. Novel 1-phenethylimidazoles
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
DE3504421A1 (de) * 1985-02-07 1986-08-07 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 11ss-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate
DE4332284C2 (de) * 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5576310A (en) * 1994-09-20 1996-11-19 Jenapharm Gmbh 11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds
PL319869A1 (en) * 1994-10-24 1997-09-01 Schering Ag Competitiveprogesterone antagonists for first-need oriented female fertility control
ZA9510926B (en) * 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
ZA962089B (en) * 1995-03-14 1997-08-27 Schering Ag Use of notric oxide donors and/or substrates or nitric oxide inhibitors for regulating cervical dilatation and extensibility

Also Published As

Publication number Publication date
NZ506048A (en) 2003-05-30
WO1999045023A1 (de) 1999-09-10
IL137851A (en) 2005-06-19
DE59905075D1 (de) 2003-05-22
EE200000500A (et) 2002-02-15
ES2197634T3 (es) 2004-01-01
NO20004362L (no) 2000-10-31
AU749163B2 (en) 2002-06-20
NO20004362D0 (no) 2000-09-01
EE04242B1 (et) 2004-02-16
KR100488823B1 (ko) 2005-05-12
SK13052000A3 (sk) 2001-11-06
BG64735B1 (bg) 2006-01-31
US6365582B1 (en) 2002-04-02
BG104712A (en) 2001-02-28
JP3796405B2 (ja) 2006-07-12
UA59437C2 (ru) 2003-09-15
IL137851A0 (en) 2001-10-31
BR9908458A (pt) 2000-11-14
NO316977B1 (no) 2004-07-12
ATE237627T1 (de) 2003-05-15
PL193687B1 (pl) 2007-03-30
AU3406799A (en) 1999-09-20
EP1060187A1 (de) 2000-12-20
DK1060187T3 (da) 2003-08-11
CN1208341C (zh) 2005-06-29
DE19809845A1 (de) 1999-09-09
JP2002505335A (ja) 2002-02-19
PL342449A1 (en) 2001-06-04
CA2322471C (en) 2007-04-24
CA2322471A1 (en) 1999-09-10
KR20010041536A (ko) 2001-05-25
IS5579A (is) 2000-07-28
HUP0100962A2 (hu) 2001-09-28
SK284177B6 (sk) 2004-10-05
EA002766B1 (ru) 2002-08-29
ID26972A (id) 2001-02-22
TR200002506T2 (tr) 2000-12-21
PT1060187E (pt) 2003-09-30
HUP0100962A3 (en) 2002-07-29
CZ20003125A3 (cs) 2002-01-16
CN1291990A (zh) 2001-04-18
EP1060187B1 (de) 2003-04-16

Similar Documents

Publication Publication Date Title
EA200000896A1 (ru) S-ЗАМЕЩЕННЫЕ ТИОЛОВЫЕ ЭФИРЫ 11b-БЕНЗАЛЬДОКСИМЭСТРА-4,9-ДИЕНУГОЛЬНОЙ КИСЛОТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЭТИ СОЕДИНЕНИЯ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
EA200100553A1 (ru) Замещенные бициклические производные, полезные в качестве противораковых агентов
BR9916790A (pt) Uso de um composto, composto, processo para amanufatura do mesmo, composição farmacêtica, e,método para produzir um efeito de dano vascularem um animal de sangue quente
EA200500088A1 (ru) Трициклические модуляторы ядерного рецептора стероидного гормона
MX9204881A (es) Composicion farmaceutica que comprende moleculas activas, receptoras de calcio.
EA199800563A1 (ru) Антагонисты гормона, высвобождающего гонадотропин
DE69830504D1 (de) Antithrombotische mitteln
EA199901016A1 (ru) 9-оксим-производные эритромицина
EA199800752A1 (ru) Пентафторбензолсульфонамиды и их аналоги
ES499870A0 (es) Un procedimiento para la preparacion de derivados de indano
EA200000785A1 (ru) Новые сульфонамидные производные в качестве ингибиторов рассасывания костной ткани и ингибиторов адгезии клеток
EA200200831A1 (ru) Фармацевтическая композиция, включающая пеметрексед вместе с монотиоглицерином, l-цистеином или тиогликолевой кислотой
PT775117E (pt) Analogos de 2-nitroimidazole fluorinados para detectar celulas de tumor hipoxicas
ATE20732T1 (de) Halogenierte proteaseinhibitoren.
EA199800155A1 (ru) Новое соединение
PT77231A (en) Process for the preparation of 2-nitro-1,1-ethenediamines having a hypotensive effect and their use for the preparation of pharmaceutical compositions with a hypotensive effect
TR200504091T2 (tr) (7alfa,17alfa)-17-hidroksi-7-metil-19-nor-17-pregn-5(10)-en 20-in-3-on içeren yüksek saflıkta bileşim.
ES480112A1 (es) Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina.
ES8102148A1 (es) Metodo de preparar 3-0-(beta-d-glucuronopiranosil)-sojasapo-genol b y similares
EA200300400A1 (ru) 17α-ФТОРАЛКИЛСТЕРОИДЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ЭТИ СОЕДИНЕНИЯ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
ES2168355T3 (es) Derivados de bisulfuro de indano-2-mercaptoacetilamida utiles como inhibidores de la encefalinasa.
EA200000772A1 (ru) Фармацевтические композиции и способы их приготовления
EA200100953A1 (ru) L-арабино-дисахариды антрациклинов, способы их получения и фармацевтические композиции, содержащие их
FI961423A (fi) Antrasykliinidisakkaridit, menetelmä niiden valmistamiseksi sekä niitä sisältävät farmaseuttiset koostumukset
MX9303902A (es) Polimeros de sacaridos lewis x y procedimiento para su preparacion.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

PC4A Registration of transfer of a eurasian patent by assignment